Company
Rondo Therapeutics
A clinical-stage company unleashing the immune system to defeat solid tumors.
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
We harness the power of the immune system to safely target and eliminate tumors. We create next-generation, immune-cell engaging bispecific antibodies for treating solid tumors.
Products
- Web
- RNDO-564
- Web
- RNDO-Program 2
- Web
- RNDO-Program 3
Loading relationship preview